of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11534  Sulfonium, bis(dihalocarbomonocycle) carbomonocycle,
salt with substituted heteropolycycle dihalo sulfoalkanoate (1:1)
(generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with
substituted heteropolycycle dihalo sulfoalkanoate (1:1) (PMN P-18-304)
is subject to reporting under this section for the significant new use
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or adhered (during the photolithographic
process) onto a semiconductor water surface or similar manufactured
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(f), (k), and (t). It is a significant new
use to import the PMN substance other than in solution, unless in
sealed containers weighing 5 kilograms or less. It is a significant new
use to process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11535   Heteropolycycle, alkylaromatic-, salt with dihalo-
substituted alkyl carbopolycycle carboxylate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified
heteropolycycle, alkylaromatic-, salt with dihalo-substituted alkyl
carbopolycycle carboxylate (PMN P-18-316) is subject to reporting under
this section for the significant new use described in paragraph (a)(2)
of this section. The requirements of this section do not apply to
quantities of the substance after

they have been completely reacted or adhered (during the
photolithographic process) onto a semiconductor water surface or
similar manufactured article used in the production of semiconductor
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(f), (k), and (t). It is a significant new
use to import the PMN substance other than in solution, unless in
sealed containers weighing 5 kilograms or less. It is a significant new
use to process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11536   Sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl
polycarbocyclic alkane-1-carboxylate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl polycarbocyclic
alkane-1-carboxylate (1:1) (PMN P-18-338) is subject to reporting under
this section for the significant new use described in paragraph (a)(2)
of this section. The requirements of this section do not apply to
quantities of the substance after they have been completely reacted or
adhered (during the photolithographic process) onto a semiconductor
water surface or similar manufactured article used in the production of
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(f), (k), and (t). It is a significant new
use to import the PMN substance other than in solution, unless in
sealed containers weighing 5 kilograms or less. It is a significant new
use to process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11537  Sulfonium, bis(dihalocarbomonocycle) carbomonocycle,
salt with dihalo substituted alkyl carbopolycyclic carboxylate (1:1)
(generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with dihalo
substituted alkyl carbopolycyclic carboxylate (1:1) (PMN P-19-76) is
subject to reporting under this section for the significant new use
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or adhered (during the photolithographic
process) onto a semiconductor water surface or similar manufactured
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(f), (k), and (t). It is a significant new
use to import the PMN substance other than in solution, unless in
sealed containers weighing 5 kilograms or less. It is a significant new
use to process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply

to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11538  Sulfonium, bis(dihalocarbomonocycle) carbomonocycle,
substituted carbomonocyclic ester (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
sulfonium, bis(dihalocarbomonocycle) carbomonocycle, substituted
carbomonocyclic ester (PMN P-19-115) is subject to reporting under this
section for the significant new use described in paragraph (a)(2) of
this section. The requirements of this section do not apply to
quantities of the substance after they have been completely reacted or
adhered (during the photolithographic process) onto a semiconductor
water surface or similar manufactured article used in the production of
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(f), (k), and (t). It is a significant new
use to import the PMN substance other than in solution, unless in
sealed containers weighing 5 kilograms or less. It is a significant new
use to process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11539  Heteropolycycle, aromatic-, salt with dihalo-
substituted alkyl carbopolycycle carboxylate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
heteropolycycle, aromatic-, salt with dihalo-substituted alkyl
carbopolycycle carboxylate (1:1) (PMN P-19-142) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section. The requirements of this section do not apply
to quantities of the substance after they have been completely reacted
or adhered (during the photolithographic process) onto a semiconductor
water surface or similar manufactured article used in the production of
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(f), (k), and (t). It is a significant new
use to import the PMN substance other than in solution, unless in
sealed containers weighing 5 kilograms or less. It is a significant new
use to process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11540  Triarylsulfonium alkylestersulfonate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
triarylsulfonium alkylestersulfonate (PMN P-19-166) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this section do
not apply to quantities of the PMN substance after they have been
completely reacted or adhered (during the photolithographic process)
onto a semiconductor water surface or similar manufactured article used
in the production of semiconductor technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.

    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v),
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i),
required human health hazard statements include acute toxicity, skin
sensitization, serious eye damage, specific target organ toxicity,
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as
specified in Sec.  721.80(f), (k), and (t). It is a significant new use
to import the PMN substance other than in solution, unless in sealed
containers weighing 5 kilograms or less. It is a significant new use to
use or process the PMN substance in any way that generates a dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11541  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-168) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), (b), and
(c). When determining which persons are reasonably likely to be exposed
as required for Sec.  721.63(a)(1) and (a)(4), engineering control
measures (e.g., enclosure or confinement of the operation, general and
local ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible. For purposes of Sec.  721.63(a)(5),
respirators must provide a National Institute for Occupational Safety
and Health (NIOSH) assigned protection factor (APF) of at least 10. For
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance
include particulate, gas/vapor (all substances in the gas form),
combination gas/vapor and particulate (gas and liquid/solid physical
states are present; a good example is paint spray mist, which contains
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (iv), and (v), and (5).
For purposes of Sec.  721.72(e), the concentration is set at 1.0%. For
purposes of Sec.  721.72(g)(1)(i), required human health hazard
statements include acute toxicity, skin sensitization, serious eye
damage, specific target organ toxicity, neurotoxicity, genetic
toxicity, and reproductive toxicity. For purposes of Sec.
721.72(g)(2)(iv), use respiratory protection or maintain workplace
airborne concentrations at or below an 8-hour time-weighted average of
0.0195 mg/m\3\. Alternative hazard and warning statements that meet the
criteria of the Globally Harmonized System and OSHA Hazard
Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11542  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-169) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), (3) through (6), (b), and
(c). When determining which persons are reasonably likely to be exposed
as required for Sec.  721.63(a)(1) and (a)(4), engineering control
measures (e.g., enclosure or confinement of the operation, general and
local ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible. For purposes of Sec.  721.63(a)(5),
respirators must provide a National Institute for Occupational Safety
and Health (NIOSH) assigned protection factor (APF) of at least 10. For
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance
include particulate, gas/vapor (all substances in the gas form),
combination gas/vapor and particulate (gas and liquid/solid physical
states are present; a good example is paint spray mist, which contains
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions

comparable to those contained in the corresponding TSCA section 5(e)
consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)(eye
and skin irritation), (g)(2)(i) through (v), and (5). For purposes of
Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11543   Halogenated benzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated benzoic acid (PMN P-19-171) is subject to reporting under
this section for the significant new use described in paragraph (a)(2)
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), (3) through (6), and (b), and
(c). When determining which persons are reasonably likely to be exposed
as required for Sec.  721.63(a)(1) and (a)(4), engineering control
measures (e.g., enclosure or confinement of the operation, general and
local ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible. For purposes of Sec.  721.63(a)(5),
respirators must provide a National Institute for Occupational Safety
and Health (NIOSH) assigned protection factor (APF) of at least 10. For
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance
include particulate, gas/vapor (all substances in the gas form),
combination gas/vapor and particulate (gas and liquid/solid physical
states are present; a good example is paint spray mist, which contains
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)(eye
and skin irritation), (g)(2)(i) through (v), and (5). For purposes of
Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11544   Halogenated benzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated benzoic acid (PMN P-19-172) is subject to reporting under
this section for the significant new use described in paragraph (a)(2)
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b),
and (c). When determining which persons are reasonably likely to be
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the operation,
general and local ventilation) or administrative control measures
(e.g., workplace policies and procedures) shall be considered and
implemented to prevent exposure, where feasible. For purposes of Sec.
721.63(a)(5), respirators must provide a National Institute for
Occupational Safety and Health (NIOSH) assigned protection factor (APF)
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne
form(s) of the substance include particulate, gas/vapor (all substances
in the gas form), combination gas/vapor and particulate (gas and
liquid/solid physical states are present; a good example is paint spray
mist, which contains both liquid droplets and vapor). For purposes of
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order

for this substance. The NCEL is 0.0195 mg/m\3\ as an 8-hour time
weighted average. Persons who wish to pursue NCELs as an alternative to
Sec.  721.63 respirator requirements may request to do so under Sec.
721.30. Persons who Sec.  721.30 requests to use the NCELs approach
that are approved by EPA will be required to follow NCELs provisions
comparable to those contained in the corresponding TSCA section 5(e)
consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), (ix)(eye and
skin irritation), (g)(2)(i) through (v), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1)(i), required human health hazard statements include acute
toxicity, skin sensitization, serious eye damage, specific target organ
toxicity, neurotoxicity, genetic toxicity, and reproductive toxicity.
For purposes of Sec.  721.72(g)(2)(iv), use respiratory protection or
maintain workplace airborne concentrations at or below an 8-hour time-
weighted average of 0.0195 mg/m\3\. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11545  Halogenated benzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated benzoic acid (PMN P-19-173) is subject to reporting under
this section for the significant new use described in paragraph (a)(2)
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b),
and (c). When determining which persons are reasonably likely to be
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the operation,
general and local ventilation) or administrative control measures
(e.g., workplace policies and procedures) shall be considered and
implemented to prevent exposure, where feasible. For purposes of Sec.
721.63(a)(5), respirators must provide a National Institute for
Occupational Safety and Health (NIOSH) assigned protection factor (APF)
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne
form(s) of the substance include particulate, gas/vapor (all substances
in the gas form), combination gas/vapor and particulate (gas and
liquid/solid physical states are present; a good example is paint spray
mist, which contains both liquid droplets and vapor). For purposes of
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)(eye
and skin irritation), (g)(2)(i) through (v), and (5). For purposes of
Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11546  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-175) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b),
and (c). When determining which persons are reasonably likely to be
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the operation,
general and local ventilation) or administrative control measures
(e.g., workplace policies and procedures) shall be considered and
implemented to prevent exposure, where feasible. For purposes of Sec.
721.63(a)(5), respirators must provide a National Institute for
Occupational Safety and Health (NIOSH) assigned protection factor (APF)
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne
form(s) of the substance include particulate, gas/vapor (all substances
in the gas form), combination gas/vapor and particulate (gas and
liquid/solid physical states are present; a good example is paint spray
mist, which contains both liquid droplets and vapor). For purposes of

Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11547  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-176) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b),
and (c). When determining which persons are reasonably likely to be
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the operation,
general and local ventilation) or administrative control measures
(e.g., workplace policies and procedures) shall be considered and
implemented to prevent exposure, where feasible. For purposes of Sec.
721.63(a)(5), respirators must provide a National Institute for
Occupational Safety and Health (NIOSH) assigned protection factor (APF)
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne
form(s) of the substance include particulate, gas/vapor (all substances
in the gas form), combination gas/vapor and particulate (gas and
liquid/solid physical states are present; a good example is paint spray
mist, which contains both liquid droplets and vapor). For purposes of
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11548   Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-177) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b),
and (c). When determining which persons are reasonably likely to be
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the operation,
general and local ventilation) or administrative control measures
(e.g., workplace policies and procedures) shall be considered and
implemented to prevent exposure, where feasible. For purposes of Sec.
721.63(a)(5), respirators must provide a National Institute for
Occupational Safety and Health (NIOSH) assigned protection factor (APF)
of at least 10. For purposes of

Sec.  721.63(a)(6), the airborne form(s) of the substance include
particulate, gas/vapor (all substances in the gas form), combination
gas/vapor and particulate (gas and liquid/solid physical states are
present; a good example is paint spray mist, which contains both liquid
droplets and vapor). For purposes of Sec.  721.63(b), the concentration
is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11549   Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-178) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), (b), and
(c). When determining which persons are reasonably likely to be exposed
as required for Sec.  721.63(a)(1) and (a)(4), engineering control
measures (e.g., enclosure or confinement of the operation, general and
local ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible. For purposes of Sec.  721.63(a)(5),
respirators must provide a National Institute for Occupational Safety
and Health (NIOSH) assigned protection factor (APF) of at least 10. For
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance
include particulate, gas/vapor (all substances in the gas form),
combination gas/vapor and particulate (gas and liquid/solid physical
states are present; a good example is paint spray mist, which contains
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11550  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated alkylbenzoic acid (PMN P-19-179) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b),
and (c). When determining which persons are reasonably likely to be
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the

operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec.  721.63(a)(5), respirators must provide a National Institute for
Occupational Safety and Health (NIOSH) assigned protection factor (APF)
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne
form(s) of the substance include particulate, gas/vapor (all substances
in the gas form), combination gas/vapor and particulate (gas and
liquid/solid physical states are present; a good example is paint spray
mist, which contains both liquid droplets and vapor). For purposes of
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue
NCELs as an alternative to Sec.  721.63 respirator requirements may
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests
to use the NCELs approach that are approved by EPA will be required to
follow NCELs provisions comparable to those contained in the
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of
Sec.  721.72(g)(1)(i), required human health hazard statements include
acute toxicity, skin sensitization, serious eye damage, specific target
organ toxicity, neurotoxicity, genetic toxicity, and reproductive
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory
protection or maintain workplace airborne concentrations at or below an
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k), (q), and (t). It is a significant new
use to manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers and processors
of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.

Sec.  721.11551  Halogenated sodium benzoate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated sodium benzoate (PMN P-19-180) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For
purposes of Sec.  721.72(g)(1)(i), required human health hazard
statements include acute toxicity, skin sensitization, serious eye
damage, specific target organ toxicity, neurotoxicity, genetic
toxicity, and reproductive toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k) and (q). It is a significant new use to
manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance. It is a significant new use to
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (c) and (f) through (i) are applicable to
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of
this section.

Sec.  721.11552  Halogenated sodium benzoate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated sodium benzoate (PMN P-19-181) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For
purposes of Sec.  721.72(g)(1)(i), required human health hazard
statements include acute toxicity, skin sensitization, serious eye
damage, specific target organ toxicity, neurotoxicity, genetic
toxicity, and reproductive toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k) and (q). It is a significant new use to
manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance. It is a significant new use to
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (c) and (f) through (i) are applicable to
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of
this section.

Sec.  721.11553   Halogenated sodium benzoate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated sodium benzoate (PMN P-19-182) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For
purposes of Sec.  721.72(g)(1)(i), required human health hazard
statements include acute toxicity, skin sensitization, serious eye
damage, specific target organ toxicity, neurotoxicity, genetic
toxicity, and reproductive toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k) and (q). It is a significant new use to
manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance. It is a significant new use to
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (c) and (f) through (i) are applicable to
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of
this section.

Sec.  721.11554  Halogenated sodium alkylbenzoate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated sodium alkylbenzoate (PMN P-19-184) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For
purposes of Sec.  721.72(g)(1)(i), required human health hazard
statements include acute toxicity, skin sensitization, serious eye
damage, specific target organ toxicity, neurotoxicity, genetic
toxicity, and reproductive toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k) and (q). It is a significant new use to
manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance. It is a significant new use to
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (c) and (f) through (i) are applicable to
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of
this section.

Sec.  721.11555  Halogenated sodium alkylbenzoate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
halogenated sodium alkylbenzoate (PMN P-19-187) is subject to reporting
under this section for the significant new use described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For
purposes of Sec.  721.72(g)(1)(i), required human health hazard
statements include acute toxicity, skin sensitization, serious eye
damage, specific target organ toxicity, neurotoxicity, genetic
toxicity, and reproductive toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k) and (q). It is a significant new use to
manufacture or process the PMN substance without including the
engineering controls/processes described in the TSCA section 5(e)
consent order for the substance. It is a significant new use to
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (c) and (f) through (i) are applicable to
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of
this section.

[FR Doc. 2020-21471 Filed 10-8-20; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 77, Number 238 (Tuesday, December 11, 2012)]
[Rules and Regulations]
[Pages 73541-73544]
[FR Doc No: 2012-29828]

========================================================================
Rules and Regulations
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains regulatory documents
having general applicability and legal effect, most of which are keyed
to and codified in the Code of Federal Regulations, which is published
under 50 titles pursuant to 44 U.S.C. 1510.

The Code of Federal Regulations is sold by the Superintendent of Documents.
Prices of new books are listed in the first FEDERAL REGISTER issue of each
week.

========================================================================

Federal Register / Vol. 77, No. 238 / Tuesday, December 11, 2012 /
Rules and Regulations

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 165

[Docket No. USCG-2012-0642]
RIN 1625-AA00

Safety Zone: Gilmerton Bridge Center Span Float-in, Elizabeth
River; Norfolk, Portsmouth, and Chesapeake, VA

AGENCY: Coast Guard, DHS.

ACTION: Interim Temporary Final Rule.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard will establish a temporary safety zone on the
navigable waters of the Elizabeth River in Norfolk, Portsmouth, and
Chesapeake, VA. This action is necessary to provide for the safety of
life on navigable waters during the Gilmerton Bridge Center Span Float-
in and bridge construction of span placement. This action is intended
to restrict vessel traffic movement to protect mariners from the
hazards associated with the float-in and span placement.

DATES: This rule will be effective from January 7, 2013 through January
16, 2013. The rule is scheduled to be enforced from 6:00 a.m. on
January 7, 2013 through January 11, 2013, with inclement weather dates
of January 12, 2013 through January 16, 2013. Comments and related
material must be received by the Coast Guard on or before December 26,
2012.

ADDRESSES: You may submit comments identified by docket number using
any one of the following methods:
    (1) Federal eRulemaking Portal: http://www.regulations.gov.
    (2) Fax:<PHONE_NUMBER>.
    (3) Mail or Delivery: Docket Management Facility (M-30), U.S.
Department of Transportation, West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC 20590-0001. Deliveries
accepted between 9 a.m. and 5 p.m., Monday through Friday, except
federal holidays. The telephone number is<PHONE_NUMBER>. See the
``Public Participation and Request for Comments'' portion of the
SUPPLEMENTARY INFORMATION section below for further instructions on
submitting comments. To avoid duplication, please use only one of these
three methods.

ADDRESSES: Documents indicated in this preamble as being available in
the docket are part of docket USCG-2012-0642 and are available online
by going to http://www.regulations.gov, inserting USCG-2012-0642 in the
``Search'' box, and then clicking ``Search.'' They are also available
for inspection or copying at the Docket Management Facility (M-30),
U.S. Department of Transportation, West Building Ground Floor, Room
W12-140, 1200 New Jersey Avenue SE., Washington, DC 20590, between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: If you have questions on this
temporary rule, call or email LCDR Hector Cintron, Waterways Management
Division Chief, Sector Hampton Roads, Coast Guard; telephone 757-668-
5581, email<EMAIL_ADDRESS>If you have questions on viewing
the docket, call Renee V. Wright, Program Manager, Docket Operations,
telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Table of Acronyms

DHS Department of Homeland Security
FR Federal Register
NPRM Notice of Proposed Rulemaking

A. Public Participation and Request for Comments

    We encourage you to participate in this rulemaking by submitting
comments and related materials. All comments received will be posted
without change to http://www.regulations.gov and will include any
personal information you have provided.

1. Submitting Comments

    If you submit a comment, please include the docket number for this
rulemaking, indicate the specific section of this document to which
each comment applies, and provide a reason for each suggestion or
recommendation. You may submit your comments and material online at
http://www.regulations.gov, or by fax, mail, or hand delivery, but
please use only one of these means. If you submit a comment online, it
will be considered received by the Coast Guard when you successfully
transmit the comment. If you fax, hand deliver, or mail your comment,
it will be considered as having been received by the Coast Guard when
it is received at the Docket Management Facility. We recommend that you
include your name and a mailing address, an email address, or a
telephone number in the body of your document so that we can contact
you if we have questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov,
type the docket number (USCG-2012-0426) in the ``SEARCH'' box and click
``SEARCH.'' Click on ``Submit a Comment'' on the line associated with
this rulemaking.
    If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. If you submit comments by mail and would
like to know that they reached the Facility, please enclose a stamped,
self-addressed postcard or envelope. We will consider all comments and
material received during the comment period and may change the rule
based on your comments.

2. Viewing Comments and Documents

    To view comments, as well as documents mentioned in this preamble
as being available in the docket, go to http://www.regulations.gov,
type the docket number (USCG-2012-0426) in the ``SEARCH'' box and click
``SEARCH.'' Click on Open Docket Folder on the line associated with
this rulemaking. You may also visit the Docket Management Facility in
Room W12-140 on the ground floor of the Department of Transportation
West Building, 1200 New Jersey Avenue SE., Washington, DC 20590,
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays.

3. Privacy Act

    Anyone can search the electronic form of comments received into any
of our dockets by the name of the

individual submitting the comment (or signing the comment, if submitted
on behalf of an association, business, labor union, etc.). You may
review a Privacy Act notice regarding our public dockets in the January
17, 2008, issue of the Federal Register (73 FR 3316).

4. Public Meeting

    We do not now plan to hold a public meeting. But you may submit a
request for one, using one of the methods specified under ADDRESSES.
Please explain why you believe a public meeting would be beneficial. If
we determine that one would aid this rulemaking, we will hold one at a
time and place announced by a later notice in the Federal Register.

B. Regulatory History and Information

    On July 25, 2012, the Coast Guard published a notice of proposed
rulemaking (NPRM) proposing a safety zone in the Gilmerton Bridge Area
(77 FR 43557) on September 5-9, 2012. We received no comments on the
proposed rule.
    Under 5 U.S.C. 553(d)(3), the Coast Guard finds that good cause
exists for making this rule effective less than 30 days after
publication in the Federal Register. Because of shifting construction
schedules, the Coast Guard was unable to determine the precise date of
the construction until recently. Therefore, waiting for a 30 day notice
period to run would have been impracticable.

C. Basis and Purpose

    On January 7, 2013 through January 11, 2013, with inclement weather
dates of January 12, 2013 through January 16, 2013, PCL Civil
Construction, Inc. will facilitate removal of the existing bascule
spans from the Gilmerton Bridge, transport of the new center span from
the Eastern Branch of the Elizabeth River at the Campostella Bridge to
the Southern Branch of the Elizabeth river at the Gilmerton Bridge in
Norfolk, Portsmouth, and Chesapeake, VA and the placement of the center
span at the Gilmerton Bridge in Chesapeake, VA. There is a danger of
falling debris during the removal of the existing structures and
installation of the new bridge span. Due to the need to protect
mariners and the public transiting the Elizabeth River from hazards
associated with the span move and construction of span placement, the
Coast Guard has determined that a moving safety zone and an extended
waterway closure at the Glimerton Bridge is necessary for public safety
purposes.

D. Discussion of Final Rule

    The Captain of the Port Hampton Roads is establishing a temporary
moving safety zone around the Gilmerton Bridge center span barge,
restricting vessels operating in the navigable waters on the Elizabeth
River from the Campostella Bridge located in the Eastern Branch of the
Elizabeth River to the Gilmerton Bridge. The purpose of this rule is to
protect mariners and the public transiting the Elizabeth River from
hazards associated with the span move, construction and placement. This
movement is scheduled to begin at 6 a.m. on January 7, 2013, weather
permitting. Because of the size of the barge and the width of the
waterway, vessels will not be able to transit around the barge,
necessitating closure of the entire waterway from the Campostella
Bridge to the Gilmerton Bridge. Transit is expected to take
approximately seven hours. This action is necessary to ensure the
safety of PCL Construction and vessels immediately prior to, during,
and following the transit of the span.
    In addition to the moving safety zone, the Coast Guard will
establish a temporary safety zone and extended waterway closure at the
Gilmerton Bridge starting at 6 a.m. on January 7, 2013, weather
permitting, until January 11, 2013. This safety zone will be
established in the interest of public safety during span placement at
the Gilmerton Bridge. The inclement weather dates are January 8, 2013
through January 12, 2013. This temporary safety zone will encompass the
waters directly under and 200 feet on either side of the Gilmerton
Bridge, crossing the Elizabeth River. Except for vessels authorized by
the Captain of the Port or his Representative, no person or vessel may
enter or remain in the safety zone during the time frame listed. Coast
Guard Captain of the Port will give notice of the enforcement of the
safety zone by all appropriate means to provide the widest
dissemination of notice among the affected segments of the public. This
will include publication in the Local Notice to Mariners and Marine
Information Broadcasts. Marine information and facsimile broadcasts may
also be made for these events, beginning 24 to 48 hours before the
event.
    While this construction was originally scheduled to commence in
September, 2012, construction has been delayed due to scheduling
concerns and other logistical issues. For these reasons, the effective
date in this final rule has been rescheduled to January 7, 2013.

E. Regulatory Analyses

    We developed this rule after considering numerous statutes and
executive orders related to rulemaking. Below we summarize our analyses
based on 13 of these statutes or executive orders.

1. Regulatory Planning and Review

    This rule is not a significant regulatory action under section 3(f)
of Executive Order 12866, Regulatory Planning and Review, as
supplemented by Executive Order 13563, Improving Regulation and
Regulatory Review, and does not require an assessment of potential
costs and benefits under section 6(a)(3) of Executive Order 12866 or
under section 1 of Executive Order 13563. The Office of Management and
Budget has not reviewed it under those Orders. The primary impact of
these regulations will be on vessels wishing to transit the affected
waterways during the moving safety zone accompanying the Glimerton
Bridge Span Barge and the safety zone at the Gilmerton Bridge beginning
at 6 a.m. on January 3, 2013 through January 7, 2013 with inclement
weather dates of January 8, 2013 through January 12, 2013. Although
these regulations prevent traffic from transiting a portion of the
Elizabeth River during these events, that restriction is limited in
duration, affects only a limited area, and will be well publicized to
allow mariners to make alternative plans for transiting the affected
area. This regulation is designed to ensure such transit is conducted
in a safe and orderly fashion.

2. Impact Small Entities

    Under the Regulatory Flexibility Act (5 U.S.C. 601-612), we have
considered the impact of this rule on small entities. The Coast Guard
certifies under 5 U.S.C. 605(b) that this rule will not have a
significant economic impact on a substantial number of small entities.
This rule will affect the following entities, some of which might be
small entities: The owners or operators of vessels intending to operate
or anchor in portions of the Elizabeth River, in Virginia. The
regulations would not have a significant impact on a substantial number
of small entities for the following reasons: The restrictions are
limited in duration, it affects only limited areas, and will be well
publicized to allow mariners to make alternative plans for transiting
the affected areas.
    If you think that your business, organization, or governmental
jurisdiction qualifies as a small entity and that this rule would have
a

significant economic impact on it, please submit a comment (see
ADDRESSES) explaining why you think it qualifies and how and to what
degree this rule would economically affect it.

3. Assistance for Small Entities

    Under section 213(a) of the Small Business Regulatory Enforcement
Fairness Act of 1996 (Public Law 104-121), we want to assist small
entities in understanding this proposed rule so that they can better
evaluate its effects on them and participate in the rulemaking. If the
rule would affect your small business, organization, or governmental
jurisdiction and you have questions concerning its provisions or
options for compliance, please contact LCDR Hector Cintron, Waterways
Management Division Chief, Sector Hampton Roads, Coast Guard; telephone
757-668-5581, email<EMAIL_ADDRESS>The Coast Guard will not
retaliate against small entities that question or complain about this
temporary rule or any policy or action of the Coast Guard.

4. Collection of Information

    This rule will call for no new collection of information under the
Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520).

5. Federalism

    A rule has implications for federalism under Executive Order 13132,
Federalism, if it has a substantial direct effect on State or local
governments and would either preempt State law or impose a substantial
direct cost of compliance on them. We have analyzed this proposed rule
under that Order and have determined that it does not have implications
for federalism.

6. Protest Activities

    The Coast Guard respects the First Amendment rights of protesters.
Protesters are asked to contact the person listed in the FOR FURTHER
INFORMATION CONTACT section to coordinate protest activities so that
your message can be received without jeopardizing the safety or
security of people, places or vessels.

7. Unfunded Mandates Reform Act

    The Unfunded Mandates Reform Act of 1995 (2 U.S.C. 1531-1538)
requires Federal agencies to assess the effects of their discretionary
regulatory actions. In particular, the Act addresses actions that may
result in the expenditure by a State, local, or tribal government, in
the aggregate, or by the private sector of $100,000,000 (adjusted for
inflation) or more in any one year. Though this rule will not result in
such an expenditure, we do discuss the effects of this rule elsewhere
in this preamble.

8. Taking of Private Property

    This rule will not cause a taking of private property or otherwise
have taking implications under Executive Order 12630, Governmental
Actions and Interference with Constitutionally Protected Property
Rights.

9. Civil Justice Reform

    This rule meets applicable standards in sections 3(a) and 3(b)(2)
of Executive Order 12988, Civil Justice Reform, to minimize litigation,
eliminate ambiguity, and reduce burden.

10. Protection of Children

    We have analyzed this rule under Executive Order 13045, Protection
of Children from Environmental Health Risks and Safety Risks. This rule
is not an economically significant rule and would not create an
environmental risk to health or risk to safety that might
disproportionately affect children.

11. Indian Tribal Governments

    This rule does not have tribal implications under Executive Order
13175, Consultation and Coordination with Indian Tribal Governments,
because it would not have a substantial direct effect on one or more
Indian tribes, on the relationship between the Federal Government and
Indian tribes, or on the distribution of power and responsibilities
between the Federal Government and Indian tribes.

12. Energy Effects

    We have analyzed this rule under Executive Order 13211, Actions
Concerning Regulations That Significantly Affect Energy Supply,
Distribution, or Use. We have determined that it is not a ``significant
energy action'' under that order because it is not a ``significant
regulatory action'' under Executive Order 12866 and is not likely to
have a significant adverse effect on the supply, distribution, or use
of energy. The Administrator of the Office of Information and
Regulatory Affairs has not designated it as a significant energy
action. Therefore, it does not require a Statement of Energy Effects
under Executive Order 13211.

13. Technical Standards

    This rule does not use technical standards. Therefore, we did not
consider the use of voluntary consensus standards.

14. Environment

    We have analyzed this rule under Department of Homeland Security
Management Directive 023-01 and Commandant Instruction M16475.lD, which
guide the Coast Guard in complying with the National Environmental
Policy Act of 1969 (NEPA) (42 U.S.C. 4321-4370f), and have made a
preliminary determination that this action is one of a category of
actions which do not individually or cumulatively have a significant
effect on the human environment. This rule is categorically excluded
from further review under paragraph 34(g) of Figure 2-1 of the
Commandant Instruction. Upon receipt of consultation comments all
documentation will be made available in the docket where indicated
under ADDRESSES. This rule involves establishing a temporary safety
zone. An environmental analysis checklist and a categorical exclusion
determination will be available in the docket where indicated under
ADDRESSES.

List of Subjects in 33 CFR Part 165

    Harbors, Marine safety, Navigation (water), Reporting and
recordkeeping requirements, Security measures, Waterways.

    For the reasons discussed in the preamble, the Coast Guard proposes
to amend 33 CFR part 165 as follows:

PART 165--REGULATED NAVIGATION AREAS AND LIMITED ACCESS AREAS

0
1. The authority citation for part 165 continues to read as follows:

    Authority: 33 U.S.C. 1231; 46 U.S.C. Chapter 701, 3306, 3703; 50
U.S.C. 191, 195; 33 CFR 1.05-1, 6.04-1, 6.04-6, 160.5; Pub. L. 107-
295, 116 Stat. 2064; Department of Homeland Security Delegation No.
0170.1.

0
2. Add temporary Sec.  165.T05-0642 to read as follows:

Sec.  165.T05-0642  Safety Zone; Gilmerton Bridge Center Span Float-in,
Elizabeth River; Norfolk, Portsmouth, and Chesapeake, Virginia.

    (a) Regulated Area. The following area is a safety zone: Regulated
Area 1: All waters of the Eastern Branch of the Elizabeth River
starting 400 feet behind the Gilmerton Bridge center span barge and
extending to the entrance of the Southern Branch of the Elizabeth River
and continuing south in the Southern Branch of Elizabeth River to the
Gilmerton Bridge in the vicinity of Norfolk, Portsmouth and Chesapeake,
VA. As the Gilmerton Bridge center span barge transits through the
waterway, the northern portions of the waterway will reopen. Regulated
Area 2: All waters of the Southern Branch of the Elizabeth River
directly under and 200 feet on either side of the Gilmerton

Bridge in the vicinity of Chesapeake, VA.
    (b) Definition. For the purposes of this part, Captain of the Port
Representative means any U.S. Coast Guard commissioned, warrant or
petty officer who has been authorized by the Captain of the Port,
Hampton Roads, Virginia to act on his behalf.
    (c) Regulations. (1) In accordance with the general regulations in
165.23 of this part, entry into this zone is prohibited unless
authorized by the Captain of the Port, Hampton Roads or his designated
representatives.
    (2) The operator of any vessel in the immediate vicinity of this
safety zone shall:
    (i) Stop the vessel immediately upon being directed to do so by any
commissioned, warrant or petty officer on shore or on board a vessel
that is displaying a U.S. Coast Guard Ensign.
    (ii) Proceed as directed by any commissioned, warrant or petty
officer on shore or on board a vessel that is displaying a U.S. Coast
Guard Ensign.
    (3) The Captain of the Port, Hampton Roads can be reached through
the Sector Duty Officer at Sector Hampton Roads in Portsmouth, Virginia
at telephone Number<PHONE_NUMBER>.
    (4) The Coast Guard Representatives enforcing the safety zone can
be contacted on VHF-FM marine band radio channel 13 (165.65Mhz) and
channel 16 (156.8 Mhz).
    (d) Enforcement Period This regulation will be enforced starting at
6 a.m. on January 3, 2013 through January 7, 2013 with inclement
weather dates of January 8, 2013 through January 12, 2013.

    Dated: November 29, 2012.
John K. Little,
Captain, U.S. Coast Guard, Captain of the Port Hampton Roads.
[FR Doc. 2012-29828 Filed 12-10-12; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 78, Number 135 (Monday, July 15, 2013)]
[Notices]
[Pages 42084-42085]
[FR Doc No: 2013-16860]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0010]

Cooperative Agreement to Support the World Trade Organization's
Standards and Trade Development Facility

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing its
intention to receive and consider a single source application for the
award of a cooperative agreement in fiscal year 2013 (FY 2013) to the
World Trade Organization's (WTO) Standards and Trade Development
Facility (STDF).

DATES: Important dates are as follows:
    1. The application due date is August 1, 2013.
    2. The anticipated start date is September 2013.
    3. The expiration date is August 2, 2013.

ADDRESSES: Submit electronic applications to: http://www.grants.gov.
For more information, see section III of the SUPPLEMENTARY INFORMATION
section of this notice.

FOR FURTHER INFORMATION CONTACT: Scientific/Programmatic Contact: Julie
Moss, Center for Food Safety and Applied Nutrition (HFS-550), Food and
Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740,
240-402-2031, email<EMAIL_ADDRESS>    Grants Management Contact: Kimberly Pendleton Chew, Office of
Acquisitions and Grant Services (HFA-500), Food and Drug
Administration, 5630 Fishers Lane, rm. 2105, Rockville, MD 20857, 301-
827-9363, email<EMAIL_ADDRESS>    For more information on this funding opportunity announcement (FOA)
and to obtain detailed requirements, please refer to the full FOA
located at www.fda.gov/food/newsevents/default.htm.

SUPPLEMENTARY INFORMATION:

I. Funding Opportunity Description

RFA-FD-13-036
93.103

A. Background

    The STDF is a unique global partnership established by the Food and
Agriculture Organization, World Organization for Animal Health, World
Bank, World Health Organization (WHO) and the WTO. The STDF supports
developing countries in building their capacity to implement
international sanitary and phytosanitary (SPS) standards, guidelines,
and recommendations as a means to improve their human, animal, and
plant health status and ability to gain or maintain access to markets.
In achieving its aims, the STDF acts as both a coordinating and a
financing mechanism.
    The STDF is a widely established knowledge platform for information
exchange, sharing experiences and the identification and dissemination
of good practice on SPS-related technical cooperation. Since 2004, over
60 projects and 52 project preparation grants have assisted developing
countries to overcome SPS constraints, and gain and maintain market
access. Over 50% have benefited least developed and other low-income
countries.
    The STDF utilizes a key decision-support tool, Multi-Criteria
Decision Analysis (MCDA), to help establish SPS priorities and ensure
resources are used as efficiently as possible. The use of the MCDA tool
is unique within the STDF and is a highly-valued attribute; the MCDA
tool facilitates an open and transparent discussion among public and
private stakeholders about capacity-building needs and resources. The
STDF is committed to the Paris Principles on Aid Effectiveness and to
achieving the Millennium Development Goals.
    With an increasingly diverse and complex global food supply, FDA's
interest is to strengthen food safety systems globally to prevent food
safety

problems rather than merely reacting to problems after they occur. FDA
recognizes that it cannot do this alone. By leveraging with other WTO
member countries and partnering with the STDF, FDA can broaden the
reach of food safety capacity building efforts.
    This cooperative agreement will allow FDA to deepen its
international food safety capacity building partnerships, provide a
wider scope of impact than exists currently and leverage resources with
other countries.

B. Research Objectives

    The purpose of this cooperative agreement is to:
    1. Contribute to the knowledge base and development of food safety
systems globally due to the increasingly diverse and complex food
supply;
    2. Enhance and broaden FDA's ability to address global food safety
and public health issues associated with food;
    3. Provide opportunities to leverage additional resources among WTO
member countries;
    4. Support FDA's Food Safety Modernization Act (FSMA) and its
International Food Safety Capacity Building Plan, which emphasizes the
concept of preventing food safety-related problems before they occur
and the importance of establishing strong relationships and mutual
support among all stakeholders, including multilateral organizations,
to improve worldwide food safety.

C. Eligibility Information

    Competition is limited to the STDF hosted by the WTO. The STDF is a
global partnership with a well-established, trusted presence and is
uniquely qualified to further the global food safety capacity building
objectives of this cooperative agreement. STDF's mandate is to: (1)
Increase awareness, mobilize resources, strengthen collaboration,
identify and disseminate good practice; and (2) provide support and
funding for the development and implementation of projects that promote
compliance with international SPS requirements.
    An independent external evaluation of the STDF in 2008 concluded
that the STDF ``carries out an important role that no other single body
would be able to accomplish.'' (Source: STDF Newsletter, Vol. 2, Issue
1, February 2009, accessible at: www.standardsfacility.org) As such,
the STDF is uniquely equipped to fulfill the objectives of this
cooperative agreement due to its diverse access to WTO members in both
developed and developing countries and its ability to coordinate
capacity building programs at a national, regional, and global level.
Engaging the STDF through this cooperative agreement will provide FDA
with ample opportunities to leverage additional resources among WTO
member countries.
    Overall, the objectives of the STDF are directly in line with the
objectives of this cooperative agreement. This ability to advance the
objectives of this cooperative agreement through member country
engagement and leveraging is a requisite for success.

II. Award Information/Funds Available

A. Award Amount

    The Center for Food Safety and Applied Nutrition intends to fund
one award up to $750,000 total costs (direct plus indirect costs) for
FY 2013. Future year amounts will depend on annual appropriations and
successful performance.

B. Length of Support

    The award will provide 1 year of support and include future
recommended support for 4 additional years, contingent upon
satisfactory performance in the achievement of project and program
reporting objectives during the preceding year and the availability of
Federal fiscal year appropriations.

III. Electronic Application, Registration, and Submission

    Only electronic applications will be accepted. To submit an
electronic application in response to this FOA, applicants should first
review the full announcement located at www.fda.gov/food/newsevents/default.htm. (FDA has verified the Web site addresses throughout this
document, but FDA is not responsible for any subsequent changes to the
Web sites after this document publishes in the Federal Register.) For
all electronically submitted applications, the following steps are
required.
     Step 1: Obtain a Dun and Bradstreet (DUNS) Number
     Step 2: Register With System for Award Management (SAM)
     Step 3: Obtain Username & Password
     Step 4: Authorized Organization Representative (AOR)
Authorization
     Step 5: Track AOR Status
     Step 6: Register With Electronic Research Administration
(eRA) Commons Steps 1 through 5, in detail, can be found at http://www07.grants.gov/applicants/organization_registration.jsp. Step 6, in
detail, can be found at https://commons.era.nih.gov/commons/registration/registrationInstructions.jsp. After you have followed
these steps, submit electronic applications to: http://www.grants.gov.

    Dated: July 10, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-16860 Filed 7-12-13; 8:45 am]
BILLING CODE 4160-01-P